Human Ubiquitin-protein Ligase E3C (UBE3C) ELISA Kit
The Human UBE3C ELISA Kit (Catalog No. ELI-44763H) is a two-site sandwich immunoassay for the quantitative determination of Human Ubiquitin-protein ligase E3C (UBE3C, also known as HECTH2/RAUL) in serum, plasma and other biological fluids. It covers a detection range of 0.156-10 ng/mL with a sensitivity of 0.078 ng/mL. The pre-coated plate, biotin-conjugated detection antibody and TMB readout at 450 nm support reproducible measurement of this HECT-domain E3 ubiquitin ligase in ubiquitin-proteasome pathway, inflammation, asthma and cancer biology research.
Product Description
Human UBE3C ELISA Kit allows for the in vitro quantitative determination of Human Ubiquitin-protein ligase E3C concentrations in serum, plasma and other biological fluids.
Target Background
UBE3C is a member of the 'homologous to E6AP C-terminus' (HECT) family of E3 ubiquitin-protein ligases and is involved in substrate protein selection for ubiquitin ligation. The UBE3C gene on chromosome 7 (band 7q36.3) encodes a HECT-domain E3 ligase that functions in the ubiquitin-proteasome pathway, the major route for selective protein degradation in eukaryotic cells. This pathway is involved in immune responses to inflammation, including asthma. Aspirin-intolerant asthma (AIA), as an asthma phenotype that involves the upper or lower airways, occurs from excessive leukotriene production on administration of nonsteroidal anti-inflammatory drugs, and the rs3802122 and rs6979947 polymorphisms of UBE3C were significantly associated with the risk of AIA. However, further studies are required to establish the underlying mechanism by which UBE3C and its polymorphisms affect the risk of AIA. Quantitative measurement of UBE3C is relevant to research into ubiquitin-proteasome signalling, inflammatory airway disease and E3 ligase biology.
Ordering Information
| Catalog No. | Product Name | Target Species | Size | Availability |
|---|
| ELI-44763H | Human Ubiquitin-protein Ligase E3C (UBE3C) ELISA Kit | Human | 96 Tests | Upon request |
Technical Specifications
| Catalog Number | ELI-44763H | Target Biomarker | Ubiquitin-protein ligase E3C (UBE3C, HECTH2/RAUL) |
| Assay Methodology | Sandwich ELISA Kit | Subcellular Location | Cytoplasm; nucleus; associated with the proteasome |
| Detection Range | 0.156-10 ng/mL | Sensitivity | 0.078 ng/mL |
| Validated Samples | serum, plasma and other biological fluids | Gene Name | UBE3C |
| Chromosomal Location | 7q36.3 | UniProt ID | Q15386 |
| Alternative Names | UBE3C, Ubiquitin-protein ligase E3C, E3 ubiquitin-protein ligase UBE3C, HECTH2, RAUL, KIAA0010, FLJ12742 | Format | 96-well microplate, 450 nm readout |
Assay Principle
This assay employs a two-site sandwich ELISA to quantitate UBE3C in Human serum and plasma. An antibody specific for UBE3C has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and any UBE3C present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for UBE3C is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of UBE3C bound in the initial step. The color development is stopped and the intensity of the color is measured.
Standard Curve and Detection Limit
The detection range is 0.156-10 ng/mL. The standard curve concentrations used for the ELISA were 10 ng/mL, 5 ng/mL, 2.5 ng/mL, 1.25 ng/mL, 0.625 ng/mL, 0.31 ng/mL, 0.156 ng/mL and 0 ng/mL. The limit of detection of Human UBE3C, defined as the analyte concentration resulting in an absorbance significantly higher than that of the dilution medium (mean plus 2 standard deviations), was determined to be 0.078 ng/mL (mean of 6 independent assays).
Assay Specificity
This assay has high sensitivity and specificity for detection of Human UBE3C. No significant cross-reactivity or interference between Human UBE3C and analogues was observed. Limited by current skills and knowledge, it is impossible to complete the cross-reactivity detection between Human UBE3C and all analogues, therefore cross-reaction may still exist.
Validation Data & Performance
5.1 Recovery
| Sample Type | Number | Recovery Range (%) | Average (%) |
|---|
| Kit-specific recovery values are not stated in the source product specification provided for this assay. Spike-recovery figures for your lot are published in the product manual available from the download banner above; always refer to the manual shipped with the kit. |
5.2 Linearity
| Sample Type | 1:2 (%) | 1:4 (%) | 1:8 (%) | 1:16 (%) |
|---|
| Kit-specific dilutional linearity values are not stated in the source product specification provided for this assay. Dilution-recovery figures for your lot are published in the product manual available from the download banner above; always refer to the manual shipped with the kit. |
5.3 Precision
| Precision Type | CV (%) |
|---|
| Intra-assay (precision within an assay, three samples tested twenty times on one plate) | CV < 10% |
| Inter-assay (precision between assays) | CV < 12% |
CV (%) = SD/mean x 100. Lot-specific precision figures are published in the product manual shipped with the kit.
Storage and Stability
| Component | Storage Condition |
|---|
| Unopened kit | Store at 2 - 8°C. Do not use past kit expiration date. |
| Opened / reconstituted reagents | May be stored for up to 1 month at 2 - 8°C. Return unused wells to the foil pouch with desiccant and reseal; protect all reagents from strong light and keep bottle caps tightly sealed. |
The stability of the ELISA kit is determined by the loss rate of activity, which is less than 5% within the expiration date under appropriate storage conditions. The valid period is six months. This kit is intended for research use only (RUO).
Key Features & Benefits
- Two-site sandwich format: The microplate is pre-coated with a capture antibody specific to UBE3C, and detection uses a biotin-conjugated antibody with streptavidin-HRP amplification, so color develops in proportion to the amount of target bound in the initial step.
- Broad dynamic range: Quantify Human UBE3C across 0.156-10 ng/mL with a sensitivity of 0.078 ng/mL, suited to both high- and low-abundance samples.
- Multiple sample types: Validated for serum, plasma and other biological fluids, supporting flexible experimental designs.
- Target specificity: Antibodies are raised against Human UBE3C and the analyte is referenced to ubiquitin-protein ligase E3C (HECTH2/RAUL), reducing cross-reactivity with unrelated proteins.
- Research-grade quality: Each kit is manufactured under controlled processes, passes strict Q.C. testing and is intended for research use only (RUO).
- Published target: UBE3C is an established research target in the ubiquitin-proteasome pathway, inflammatory airway disease and cancer biology; see the scientific literature section for representative PubMed references.
Scientific Literature & References
- Lee JS, Kim JH, Bae JS, Kim JY, Park TJ, Pasaje CF, Park BL, Cheong HS, Park JS, Uh ST, Kim MK, Choi IS, Cho SH, Choi BW, Park CS, Shin HD (2010). Association analysis of UBE3C polymorphisms in Korean aspirin-intolerant asthmatic patients. Ann Allergy Asthma Immunol, 105(4):307-312. PubMed ID: 20934631
- Pasaje CF, Kim JH, Park BL, Park JS, Uh ST, Kim MK, Park CS, Shin HD (2011). UBE3C genetic variations as potent markers of nasal polyps in Korean asthma patients. J Hum Genet, 56(11):797-800. PubMed ID: 21881582
- Jiang JH, Liu YF, Ke AW, Gu FM, Yu Y, Dai Z, Gao Q, Shi GM, Liao BY, Xie YH, Fan J, Huang XW, Zhou J (2014). Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing. Hepatology, 59(6):2216-2227. PubMed ID: 24425307
- Wen JL, Wen XF, Li RB, Jin YC, Wang XL, Zhou L, Chen HX (2015). UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt/beta-catenin pathway. PLoS One, 10(2):e0115622. PubMed ID: 25658088
- Zhang Y, Xu J, Fu H, Wei Z, Yang D, Yan R (2021). UBE3C promotes proliferation and inhibits apoptosis by activating the beta-catenin signaling via degradation of AXIN1 in gastric cancer. Carcinogenesis, 42(3):431-440. PubMed ID: 32930707
Academic FAQ
What is UBE3C protein?
UBE3C is the gene that encodes ubiquitin-protein ligase E3C, a member of the 'homologous to E6AP C-terminus' (HECT) family of E3 ubiquitin-protein ligases. The gene is located on chromosome 7 at band 7q36.3, and the encoded protein is assigned UniProt identifier Q15386 and is also known by the aliases HECTH2 and RAUL. As a HECT-domain E3 ligase, UBE3C catalyses the final step of ubiquitin conjugation, transferring ubiquitin from a thioester-linked E2~ubiquitin intermediate onto substrate proteins and assembling polyubiquitin chains. It is involved in substrate protein selection for ubiquitin ligation and functions within the ubiquitin-proteasome pathway, the principal system for selective protein degradation in eukaryotic cells, and it has been reported to associate with the proteasome. Through its role in this pathway, UBE3C participates in processes such as immune responses to inflammation, including asthma; the UBE3C polymorphisms rs3802122 and rs6979947 were significantly associated with the risk of aspirin-intolerant asthma in a Korean cohort, and further studies are required to establish the underlying mechanism. UBE3C has also been implicated in tumour growth and metastasis in several cancers, making it a subject of interest in cancer biology. A sandwich ELISA directed against UBE3C provides a quantitative readout of this E3 ligase in tissue and fluid samples.
How does the Sandwich ELISA principle work?
A sandwich ELISA uses a microtiter plate pre-coated with a capture antibody specific to the target protein. Standards and unknown samples are added to the wells so the target binds to the immobilized capture antibody during an incubation step, after which unbound material is removed by washing. A biotin-conjugated detection antibody is then added; it binds a second, distinct epitope on the captured protein, forming an antibody-target-antibody sandwich. Streptavidin conjugated to horseradish peroxidase (HRP) is added and binds the biotin on the detection antibody. Following another wash to remove excess conjugate, the substrate solution is added; HRP converts the substrate into a coloured product whose intensity is proportional to the amount of target captured. The reaction is stopped and absorbance is measured at 450 nm, and the target concentration in each sample is derived by comparing the optical density to a standard curve run on the same plate. Interpolation from this curve converts absorbance into absolute concentration.
Which sample types are compatible with this kit?
This kit is validated for serum, plasma and other biological fluids. For serum, use a serum separator tube and allow samples to clot for two hours at room temperature or overnight at 2-8°C before centrifugation for 15 minutes at 1000 x g; remove the serum and assay immediately or aliquot and store at ≤ -20°C. For plasma, collect using EDTA or heparin as an anticoagulant and centrifuge for 15 minutes at 1000 x g at 2-8°C within 30 minutes of collection, then assay immediately or aliquot and store at ≤ -20°C. For other biological fluids, centrifuge for 20 minutes at 1000 x g, remove particulates, and assay immediately or store aliquots at -20°C or -80°C. Samples to be used within 5 days may be stored at 2-8°C; otherwise store at -20°C (up to 1 month) or -80°C (up to 2 months). Avoid repeated freeze-thaw cycles, bring all samples to room temperature before the assay, and note that hemolytic specimens are not suitable because hemolysis influences the result.
What are the storage requirements for this kit?
Unopened kits should be stored at 2-8°C and must not be used past the expiration date printed on the kit label. After opening or reconstitution, the coated assay plate, standard, biotin-conjugate, streptavidin-HRP, sample diluent, conjugate diluents, wash buffer, substrate solution and stop solution may be stored for up to 1 month at 2-8°C; the standard should additionally be kept at -20°C if not for recent use. Return unused wells to the foil pouch containing the desiccant pack, reseal along the entire edge of the zip-seal and avoid damp. Protect all reagents from strong light during storage and incubation, keep bottle caps tightly sealed to prevent evaporation and microbial contamination, and do not mix or substitute reagents from other lots or sources. The valid period of the kit is six months.
What is the difference between UBE3C and UBE3A?
UBE3C and UBE3A are two distinct human genes that both encode HECT-domain E3 ubiquitin-protein ligases, and they differ in chromosomal location, substrate specificity and disease association. UBE3C is located on chromosome 7 at band 7q36.3 and encodes ubiquitin-protein ligase E3C (UniProt Q15386, also known as HECTH2/RAUL), while UBE3A is located on chromosome 15 and encodes the E6AP ubiquitin-protein ligase (the Angelman syndrome gene). Both enzymes catalyse the transfer of ubiquitin onto substrate proteins through a conserved HECT domain, but they recognise different substrates and assemble polyubiquitin chains with different linkages. UBE3C has been studied mainly in the ubiquitin-proteasome pathway, inflammatory airway disease (its polymorphisms are associated with aspirin-intolerant asthma) and tumour growth and metastasis, whereas loss of UBE3A function in the brain causes Angelman syndrome, a neurodevelopmental disorder, and UBE3A duplication is associated with autism spectrum features. Because the two ligases are distinct proteins with different biology, they should be measured separately with target-specific assays and interpreted against their respective calibrators.
Research Use Only: This product is for research use only (RUO) and is not intended for diagnostic, therapeutic or human use.
Nova Lifetech Inc.
Tel: (852)-81700488
Website: www.lifescience-market.com
Please have the lot number of the kit ready (found on the outside of the box) when contacting technical support.